Therapeutic Cataract & Refractive

Resolving eye care disparities can yield positive results for patients of all backgrounds.

According to the UK study, for every 0.5-diopter increase in mean spherical equivalent, a 6% higher risk was attributed in developing depressive disorders.

Removing drops improves adherence and comfort for most patients.

Technological advancements may improve treatment options.

The pachymeter is the most lightweight handheld product of its kind on the market, according to the company.

Considering recovery time, potential adverse effects, and future eye care needs can increase patient satisfaction.

Even if DLS is completely normal and expected, it can be mentally and emotionally difficult for patients.

This neural time warp is seen throughout the optometric examination.

Annual meeting places spotlight on newest clinical techniques, industry trends.

New and returning special events and features on tap at annual meeting

The aspheric, monofocal, single-piece C-loop IOL from Zeiss compensates for a range of spherical aberrations to minimize decentration and lens misalignments.

Nasal spray may fill the gaps left by artificial tears.

The pros and cons of LASIK, PRK, EVO, SMILE, and RLE/CLE.

Ashley Wallace-Tucker, OD, FAAO, FSLS, Dipl ABO, shares key takeaways from her SECO 2023 panel discussion, "Myopia management."

Investigators evaluated and compared the long-term formation of posterior capsular opacification (PCO) and the rate of glistenings that developed between 2 hydrophobic acrylic intraocular lenses (IOLs).

Smaller corneal incisions made during cataract surgery are linked with better visual outcomes and less frequent postoperative endophthalmitis.

See the results from our recent poll!

A look back on what's happened in optometry during the week of February 11-February 16.

Medical and surgical technological advances show promise for future glaucoma management.

Advances in drug creation would reduce cost burden of treatment for patients.

A look back on what's happened in optometry during the week of February 4-February 9.

Flavio Mantelli, MD, PhD, Chief Medical Officer at Dompé, shares about the company's role in nerve growth factor (NGF) applications in ophthalmic disease and other human indications.

A look back on what's happened in optometry during the week of Jan. 28-Feb. 2.

A look back on what's happened in optometry during the week of Jan. 21-Jan. 26.

Researchers found that prompt intervention may improve the prognosis of fungal endophthalmitis caused by contaminated medical products.